Moreover, RAGE inhibitors like azeliragon and FPS-ZM1, nano-medicines and nano-particles targeting AGE-RAGE axis, and natural polyphenols inhibiting AGEs, in combination with synbiotics, all need to be evaluated further in clinical trials to be employed as combination agents with conventional chemotherapy for cancer. This evidence concerns the gene AGER and cancer.